Cyclooxygenase-2-mediated regulation of Kupffer cell interleukin-6 production following trauma-hemorrhage and subsequent sepsis

Shock

Volumn 16, Issue 6, 2001, Pages 479-483

  Knöferl, Markus W ^a,d   Diodato, Michael D ^a   Schwacha, Martin G ^b   Cioffi, William G ^a   Bland, Kirby I ^b   Chaudry, Irshad H ^b,c  

^a BROWN UNIVERSITY   (United States)

^b Kentucky   (United States)

^c UNIVERSITY OF ALABAMA SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF ULM   (Germany)

Author keywords

IL 1 ; Immunomodulation; Inflammation; PGE2; TNF

Indexed keywords

AUTACOID; CYCLOOXYGENASE 2; INTERLEUKIN 6; ISOENZYME; N (2 CYCLOHEXYLOXY 4 NITROPHENYL)METHANESULFONAMIDE; NITROBENZENE DERIVATIVE; PROSTAGLANDIN E2; PROSTAGLANDIN SYNTHASE; PROSTAGLANDIN SYNTHASE INHIBITOR; SULFONAMIDE; TUMOR NECROSIS FACTOR;

ANIMAL; ARTICLE; BIOSYNTHESIS; BLOOD; DRUG EFFECT; ENZYMOLOGY; HEMORRHAGIC SHOCK; IMMUNOLOGY; IN VITRO STUDY; INJURY; KUPFFER CELL; MALE; METABOLISM; MOUSE; MOUSE STRAIN; SEPSIS;

ANIMAL; CYCLOOXYGENASE INHIBITORS; DINOPROSTONE; IN VITRO; INFLAMMATION MEDIATORS; INTERLEUKIN-6; ISOENZYMES; KUPFFER CELLS; MALE; MICE; MICE, INBRED C3H; NITROBENZENES; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASE; SEPSIS; SHOCK, HEMORRHAGIC; SULFONAMIDES; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; TUMOR NECROSIS FACTOR; WOUNDS AND INJURIES;

EID: 0035654688     PISSN: 10732322     EISSN: None     Source Type: Journal    
DOI: 10.1097/00024382-200116060-00013     Document Type: Article

References (35)

1. O'Neill PJ, Ayala A, Wang P, Ba ZF, Morrison MH, Schultze AE, Reich SS, Chaudry IH: Role of Kupffer cells in interleukin-6 release following trauma-hemorrhage and resuscitation. Shock 1:43-47, 1994.
2. Ertel W, Morrison MH, Ayala A, Chaudry IH: Chloroquine attenuates hemorrhagic shock induced suppression of Kupffer cell antigen presentation and MHC class II antigen expression through blockade of tumor necrosis factor and prostaglandin release. Blood 78:1781-1788, 1991.
3. Zellweger R, Ayala A, DeMaso CM, Chaudry IH: Trauma-hemorrhage causes prolonged depression in cellular immunity. Shock 4:149-153, 1995.
4. Ayala A, Lehman DL, Herdon CD, Chaudry IH: Mechanism of enhanced susceptibility to sepsis following hemorrhage: Interleukin (IL)-10 suppression of T-cell response is mediated by eicosanoid induced IL-4 release. Arch Surg 129:1172-1178, 1994.
5. Ertel W, Morrison MH, Ayala A, Perrin MM, Chaudry IH: Blockade of prostaglandin production increases cachectin synthesis and prevents depression of macrophage functions following hemorrhagic shock. Ann Surg 213:265-271, 1991.
6. Ertel W, Morrison MH, Meldrum DR, Ayala A, Chaudry IH: Ibuprofen restores cellular immunity and decreases susceptibility to sepsis following hemorrhage. J Surg Res 53:55-61, 1992.
7. O'Neill GP, Ford-Hutchinson AW: Expression of mRNA for cyclooxygenase-1 and cyclooxygenase-2 in human tissues. FEBS Lett 330:156-160, 1993.
8. Kulkarni SK, Jain NK, Singh A: Cyclooxygenase isoenzymes and newer therapeutic potential for selective COX-2 inhibitors. Methods Find Exp Clin Pharmacol 22:291-298, 2000.
9. Fu JY, Masferrer JL, Seibert K, Raz A, Needleman P: The induction and suppression of prostaglandin H2 synthase (cyclooxygenase) in human monocytes. J Biol Chem 65:16737-16740, 1990.
10. Niiro H, Otsuka T, Izuhara K, Yamaoka K, Ohshima K, Tanabe T, Hara S, Nemoto Y, Tanaka Y, Nakashima H, Niho Y: Regulation by interleukin-10 and interleukin-4 of cyclooxygenase-2 expression in human neutrophils. Blood 89:1621-1628, 1997.
11. Hla T, Neilson K: Human cyclooxygenase-2 cDNA. Proc Natl Acad Sci USA 89:7384-7388, 1992.
12. Masferrer JL, Isakson PC, Seibert K: Cyclooxygenase-2 inhibitors: a new class of anti-inflammatory agents that spare the gastrointestinal tract. Gastroenterol Clin North Am 25:363-372, 1996.
13. Masferrer JL, Zweifel BS, Manning PT, Hauser SD, Leahy KM, Smith WG, Isakson PC, Seibert K: Selective inhibition of inducible cyclooxygenase 2 in vivo is anti-inflammatory and nonulcerogenic. Proc Natl Acad Sci USA 91:3228-3232, 1994.
14. Kishimoto Y, Wada K, Nakamoto K, Kawasaki H, Hasegawa J: Levels of cyclooxygenase-1 and -2 mRNA expression at various stages of acute gastric injury induced by ischemia-reperfusion in rats. Arch Biochem Biophys 352:153-157, 1998.
15. Futaki N, Takahashi S, Kitagawa T, Yamakawa Y, Tanaka M, Higuchi S: Selective inhibition of cyclooxygenase-2 by NS-398 in endotoxin shock rats in vivo. Inflamm Res 46:496-502, 1997.
16. Liu SF, Newton R, Evans TW, Barnes PJ: Differential regulation of cyclooxygenase-1 and cyclo-oxygenase-2 gene expression by lipopolysaccharide treatment in vivo in the rat. Clin Sci 90:301-306, 1996.
17. Ayala A, Chaudry IH: Immune dysfunction in murine polymicrobial sepsis: mediators, macrophages, lymphocytes and apoptosis. Shock 6:27-38, 1996.
18. Shoup M, He LK, Liu H, Shankar R, Gamelli R: Cyclooxygenase-2 inhibitor NS-398 improves survival and restores leukocyte counts in burn infection. J Trauma 45:215-220, 1998.
19. 2 after trauma attenuates proinflammatory cytokines and improves survival. Shock 14:374-379, 2000.
20. Baker CC, Chaudry IH, Gaines HO, Baue AE: Evaluation of factors affecting mortality rate after sepsis in murine cecal ligation and puncture model. Surgery 94:331-335, 1983.
21. Ayala A, Perrin MM, Ertel W, Chaudry IH: Differential effects of haemorrhage on Kupffer cells: decreased antigen presentation despite increased inflammatory cytokine (IL-1, IL-6 and TNF) release. Cytokine 4:66-75, 1992.
22. Ihle JN, Keller J, Greenberger JS, Henderson L, Yetter RA, Morse HC: Phenotypic characteristics of cell lines requiring IL-3 for growth. J Immunol 129:1377-1383, 1982.
23. Ayala A, Perrin MM, Kisala JM, Ertel W, Chaudry IH: Polymicrobial sepsis selectively activates peritoneal but not alveolar macrophage to release inflammatory mediators (IL-1, IL-6 and TNF). Circ Shock 36:191-199, 1992.
24. Mizel SB: Production and quantitation of lymphocyte-activating factor (interleukin 1). In Herscowitz HB, Holden HT, Bellanti JA, Ghaffar A (ed): Manual of Macrophage Methodology. New York: Marcel Dekker, 1981, pp. 407-441.
25. Ertel W, Morrison MH, Wang P, Ba ZF, Ayala A, Chaudry IH: The complex pattern of cytokines in sepsis: association between prostaglandins, cachectin and interleukins. Ann Surg 214:141-148, 1991.
26. Ebong S, Call D, Nemzek J, Bolgos G, Newcomb D, Remick DG: Immunopathologic alterations in murine models of sepsis of increasing severity. Infect Immun 67:6603-6610, 1999.
27. 2 by LPS-stimulated rat bone marrow macrophages after thermal injury: effect of indomethacin. Inflammation 18:175-185, 1994.
28. 2: the role of p38 mitogen-activated protein kinase. J Interferon Cytokine Res 20:291-298, 2000.
29. 2 in human osteoblasts, MG-63 cells. J Biochem 126:553-558, 1999.
30. Anderson GD, Hauser SD, McGarity KL, Bremer ME, Isakson PC, Gregory SA: Selective inhibition of cyclooxygenase (COX)-2 reverses inflammation and expression of COX-2 and interleukin 6 in rat adjuvant arthritis. J Clin Invest 97:2672-2679, 1996.
31. Taniguchi T, Koido Y, Aiboshi J, Yamashita T, Suzaki S, Kurokawa A: Change in the ratio of interleukin-6 to interleukin-10 predicts a poor outcome in patients with systemic inflammatory response syndrome. Crit Care Med 27:1262-1264, 1999.
32. Terregino CA, Lopez BL, Karras DJ, Killian AJ, Arnold GK: Endogenous mediators in emergency department patients with presumed sepsis: are levels associated with progression to severe sepsis and death? Ann Emerg Med 35: 26-34, 2000.
33. O'Reilly M, Newcomb DE, Remick D: Endotoxin, sepsis and the primrose path. Shock 12:411-420, 1999.
34. 2 regulates macrophage-derived tumor necrosis factor gene expression. J Biol Chem 263:5380-5384, 1988.
35. Schwacha MG, Knöferl MW, Samy TSA, Ayala A, Chaudry IH: The immunologic consequences of hemorrhagic shock. Crit Care Shock 2:42-64, 1999.